Trial Profile
Phase II Clinical Study of Interferon+Sorafenib Combination Therapy in Advanced Renal Cell Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Interferon alpha
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 17 May 2016 New trial record